Trexquant Investment LP increased its holdings in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 83.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89,977 shares of the insurance provider's stock after purchasing an additional 41,053 shares during the period. Trexquant Investment LP's holdings in Allstate were worth $18,632,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in ALL. Brighton Jones LLC raised its holdings in shares of Allstate by 60.2% during the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider's stock worth $1,253,000 after purchasing an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC purchased a new position in shares of Allstate during the fourth quarter worth $231,000. The Manufacturers Life Insurance Company raised its holdings in shares of Allstate by 68.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 454,655 shares of the insurance provider's stock worth $87,653,000 after purchasing an additional 184,947 shares during the last quarter. Lido Advisors LLC raised its holdings in shares of Allstate by 6.7% during the fourth quarter. Lido Advisors LLC now owns 34,085 shares of the insurance provider's stock worth $6,601,000 after purchasing an additional 2,153 shares during the last quarter. Finally, Voleon Capital Management LP purchased a new position in Allstate in the fourth quarter valued at $3,009,000. Hedge funds and other institutional investors own 76.47% of the company's stock.
Allstate Price Performance
ALL traded down $0.13 on Monday, reaching $203.63. 993,048 shares of the company's stock were exchanged, compared to its average volume of 1,240,477. The stock has a market cap of $53.66 billion, a PE ratio of 9.57, a P/E/G ratio of 0.82 and a beta of 0.37. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $214.76. The stock's fifty day moving average price is $199.81 and its 200-day moving average price is $199.57. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, topping analysts' consensus estimates of $3.20 by $2.74. The firm had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. Allstate's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.61 earnings per share. Sell-side analysts expect that The Allstate Corporation will post 18.74 EPS for the current year.
Allstate Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 2.0%. The ex-dividend date is Friday, August 29th. Allstate's payout ratio is presently 18.81%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on ALL shares. UBS Group lifted their price objective on shares of Allstate from $230.00 to $235.00 and gave the company a "buy" rating in a report on Wednesday, July 9th. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a report on Tuesday, August 5th. Citigroup raised shares of Allstate to a "hold" rating in a report on Wednesday, August 13th. Keefe, Bruyette & Woods lifted their price objective on shares of Allstate from $237.00 to $246.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. Finally, BMO Capital Markets lifted their target price on shares of Allstate from $230.00 to $235.00 and gave the company an "outperform" rating in a research report on Wednesday, August 20th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $230.73.
Check Out Our Latest Report on Allstate
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.